Talc pleurodesis (TP) is a technique, widely employed in the management of patients with persistent pleural effusions or pneumothoraces not amenable to other treatment options. It is well documented that talc deposits produce areas of highly increased 18 F-FDG uptake, because of talcinduced inflammation. We present a case of a patient with history of TP who was evaluated with both 18 F-FDG and 68 Ga-DOTA-TATE. The hypermetabolic area seen on 18 F-FDG-PET-CT in the region of talc placement showed no uptake by 68 Ga-DOTA-TATE, suggesting the potential role of 68 Ga-DOTA-TATE-PET-CT in elucidating 18 F-FDG-postitive lesions in patients with history of both neuroendocrine malignancy and TP.
. A 51-year-old woman with history of multiple endocrine neoplasia type 1 (MEN-1) underwent resection of an anterior mediastinal mass, which was histologically proven to be a WHO type B3, Masaoka stage III thymoma. Postoperatively, the patient developed right-sided chylothorax, which was initially treated with chest tube, octreotide therapy, and low fat diet to decrease chyle fluid production. Because of recurrent pleural fluid, the patient underwent thoracic duct ligation via video-assisted thoracoscopic surgery and TP, which resulted in resolution of her chylothorax. Repeated follow-up 18 F-FDG-PET/CT studies showed intensely increased uptake (SUVmax: 27.5), in the posterior right cardiophrenic angle (A) 18 F-FDG-PET coronal image, and (B) 18 F-FDG-PET/CT coronal image, corresponding to pleural thickening seen on CT (C) CT coronal image. Based on the patient's history of talc placement in this specific region, the increased 18 F-FDG uptake was attributed to talc-induced inflammation. On follow-up 2 years after TP, both 18 F-FDG-PET/CT and 68 Ga-DOTA-TATE-PET/CT studies were performed. Again, 18 F-FDG-PET/CT showed increased hypermetabolic activity (SUVmax: 26.0) in the region of talc-placement, whereas PET/CT using 68 Ga-DOTA-TATE showed no uptake (D) 68 Ga-DOTA-TATE-PET/CT coronal image. Talc pleurodesis is an established, highly efficient technique for the treatment of patients with persistent benign or malignant pleural effusions, recurrent pneumothoraces, and persistent bronchopleural fistulas. [1] [2] [3] Pathological studies have shown the acute development of both visceral and parietal pleural granulomatous inflammation with intensive proliferation of fibroblasts after talc administration. Subsequently, collagen production and formation of strong adhesive links between the visceral and parietal pleural surfaces leads to pleural fibrosis and obliteration of the pleural space. 1, 4, 5 It is well established, 6-20 that talc deposits in the pleura produce areas of increased 18 F-FDG uptake, for up to 48 years after the performance of TP. 18 Distinguishing pleural malignancy from talc-induced benign inflammatory changes is challenging by 18 F-FDG, especially in patients with history of both thoracic malignancy and TP. This diagnostic dilemma becomes even greater, when pulmonary parenchymal nodules develop because of talc-particle absorption through the pleura, with avid 18 F-FDG uptake. 9 Because 18 F-FDG is not a malignancy-specific agent, the use of 18 F-FDG-PET/CT imaging can lead to misinterpretation and false upstaging in patients with history of TP. It has been reported that somatostatin receptors (SSTRs) are expressed and upregulated on human macrophages, [21] [22] [23] suggesting the potential role of PET/CT using 68 Ga-DOTA-conjugated peptides (SST analogues) for evaluation of sites of talc-induced inflammation. To our knowledge, we present the first report of a patient with history of TP who underwent PET/CT using 68 Ga-DOTA-TATE, which has a predominant affinity for SSTR subtype 2. There was no 68 Ga-DOTA-TATE uptake (D) by the corresponding hypermetabolic area, indicating lack of SSTRs expression at sites of chronic talc-induced inflammation. On the other hand, most neuroendocrine tumors overexpress SSTRs and can be effectively targeted and localized using radiolabeled SST analogues. 24 Thus, the presented findings in a patient with history of multiple neuroendocrine tumors and TP indicate that 68 Ga-DOTA-TATE-PET/CT has a potential role in differentiating between neuroendocrine malignancy and talc-induced benign inflammatory processes.
